This announcement is a separate document:
ジーテクト：半期報告書－第14期(2024/04/01－2025/03/31)
G-Tekt: Half Year Report - Term 14 (2024/04/01 - 2025/03/31)
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Related Stocks Related Stocks
Symbol Mini Chart Price
Unlock the Full List
Latest
08:27
CITIC SEC: The Outlook for the Sustainable Realization of Monopoly-type Dividends in 2025 is Stronger.
CITIC+0.33%
08:27
The interbank main interest rate bond yields generally declined at the beginning, with the 10-year policy bank bond "24 Policy Bank 15" yield down 0.75bp to 1.63%, the 10-year national treasury bond "24 Coupon National Treasury Bond 11" yield down 0.6bp to 1.5840%, and the 30-year national treasury bond "24 Special National Treasury Bond 06" yield down 1.25bp to 1.8250%.
08:24
WUXI BIO and Candid Therapeutics have reached a research service collaboration on T-cell bridging trispecific antibodies.
WUXI BIO-2.35%
Statement
This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.